Resident and inflammatory mononuclear phagocytes (MPhs) with functional plasticity in the intestine are critically involved in the pathology of inflammatory bowel diseases (IBDs), the mechanism of which remains incompletely understood. In the present study, we found that increased expression of the E3 ligase F-box and WD repeat domain-containing 7 (FBXW) in the inflamed intestine was significantly correlated with IBD severity in both human diseases and in mouse models. Myeloid Fbxw7 deficiency protected mice from colitis induced by dextran sodium sulfate (DSS) or 2,6,4-trinitrobenzene sulfonic acid (TNBS). Fbxw7 deficiency resulted in decreased production of the chemokines CCL2 and CCL7 by colonic CX3CR1 hi resident macrophages and reduced the accumulation of CX3CR1 int proinflammatory MPhs in colitis-affected colon tissue. Mice that received adeno-associated virus-shFbxw7 (AAV-shFbxw7) showed significantly improved survival rates and alleviation of colitis. Mechanism screening demonstrated that FBXW7 suppressed H3K27me3 modification and promoted Ccl2 and Ccl7 expression via degradation of the histone-lysine N-methyltransferase enhancer of zeste homolog 2 (EZH2) in macrophages. Taken together, our results indicate that FBXW7 degrades EZH2 and increases Ccl2 and Ccl7 in CX3CR1 hi macrophages, thereby promoting the recruitment of CX3CR1 int proinflammatory MPhs into local colon tissues with colitis. Targeting FBXW7 might represent a potential therapeutic approach for the treatment of intestinal inflammation.
Introduction
Chronic and progressive inflammation is the key pathogenesis of inflammatory bowel disease (IBD) including Crohn's disease (CD) and ulcerative colitis (UC), which involve dysregulation of the genetic, environmental, or microbial factors and immune responses. A macrophage-induced innate immune response within the intestinal mucosa is the first line of defense against the invading pathogens (1-3). Inefficient or overactivation of gastrointestinal macro phage subsets participate in IBD development by regulating the initiation, amplification, and resolution of local inflammation (4) (5) (6) .
Monocyte-derived mononuclear phagocytes (MPhs) in colonic lamina propria (CLP) express certain levels of the chemokine CX3C receptor CX3CR1 and CD11b (7, 8) . In a healthy colon, Ly6C hi (Ly6C high-positive) monocytes mainly give rise to CX3CR1 hi (CX3CR1 high-positive) resident macrophages that contribute to the maintenance of gut homeostasis and protect the host from certain pathogens (9, 10) . However, the phenotype and fate of mucosal monocyte-derived MPhs change dramatically in inflammatory environments. Under these circumstances, CX3CR1 hi resident macrophages that dominate in the healthy colon are replaced by inflammation-elicited plastic CX3CR1 int (CX3CR1 intermediatepositive) MPhs that are the progeny of rapidly infiltrating Ly6C hi circulating peripheral blood monocytes (11) , which express higher levels of proinflammatory mediators and TLRs, NO, reactive oxygen intermediates, cathepsins, and metalloproteases than do their resident counterparts, forming an intense infiltration into CLP. As a result, CX3CR1 int proinflammatory MPhs aggravate the intestinal inflammatory response and play crucial roles in the pathogenesis of CD and UC (7) . Although the cells in this MPh pool are on a differentiation waterfall that may include cell populations that have predominantly more macrophage-like functions, there are also a small number of cells with DC-like functions (10) . Therefore, herein, we refer to CLP CX3CR1 int macrophages as CX3CR1 int MPhs.
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Fbxw7 increases CCL2/7 in CX3CR1 hi macrophages to promote intestinal inflammation Jia He, 1 Yinjing Song, 1 Gaopeng Li, 1 Peng Xiao, 2 Yang Liu, 1 Yue Xue, 1 Qian Cao, 2 Xintao Tu, 1 Ting Pan, 1 Zhinong Jiang, 3 Xuetao Cao, 1, 4 Lihua Lai, 1 and Qingqing Wang 1 2E) and F4/80 + macrophages ( Figure 2F ) after DSS treatment for 5 days compared with expression in the colons of healthy mice. These results suggest that increased FBXW7 expression in monocytes and macrophages was correlated with local colonic inflammation in both humans and mice.
Fbxw7 deficiency attenuates experimental colitis. To investigate the role of Fbxw7 in macrophages in colitis, LysM-Cre + Fbxw7 fl/fl (LysM + Fbxw7 fl/fl ) mice and their control littermates (Fbxw7 fl/fl ) were subjected to acute colitis induction using 3% DSS. Colitisinduced macroscopic changes (body weight loss, diarrhea, and rectal bleeding) were significantly alleviated in the LysM + Fbxw7 fl/fl mice compared with Fbxw7 fl/fl littermates ( Figure 3A) . LysM + Fbxw7 fl/fl mice sacrificed on day 9 displayed significantly longer colons ( Figure 3B ), milder epithelial damage, and deceased areas of mucosal ulceration ( Figure 3C and Supplemental Figure 2A ) compared with Fbxw7 fl/fl littermates. Moreover, expression levels of the tight junction genes Cldn1, Cldn2, Ocln, and Tjp1 (Supplemental Figure 2B ) and of TJP1 protein (Supplemental Figure 2C ) were significantly higher in the epithelia of LysM + Fbxw7 fl/fl mice compared with Fbxw7 fl/fl littermates after DSS treatment, which indicated that the epithelial barrier integrity was less disrupted in mice with myeloid-specific Fbxw7 deficiency. At the same time, LysM + Fbxw7 fl/fl mice showed significantly improved survival rates compared with Fbxw7 fl/fl littermates after 4% DSS treatment ( Figure 3D ), indicating that Fbxw7 deficiency protects mice from DSS-induced colitis.
During the recovery period of intestinal inflammation, the rate of body weight gain was more rapid in LysM + Fbxw7 fl/fl mice than in Fbxw7 fl/fl littermates ( Figure 3E ). Moreover, LysM + Fbxw7 fl/fl mice had longer colon lengths than did their Fbxw7 fl/fl littermates ( Figure 3F ) on day 15. Similarly, TNBS-induced colon shortening, the disease activity index (DAI), body weight loss, and epithelial damage were also alleviated in LysM + Fbxw7 fl/fl mice compared with Fbxw7 fl/fl littermates (Supplemental Figure  3 , A-D). These findings indicate that myeloid Fbxw7 deficiency attenuates experimental colitis.
Fbxw7 deficiency decreases proinflammatory MPh accumulation. Microbiota-induced inflammation is critical for the regulation of intestinal homeostasis. To determine whether the decreased DSS colitis susceptibility in LysM + Fbxw7 fl/fl mice was mediated by shifts in gut microbiota, we analyzed the fecal microbiota composition in LysM + Fbxw7 fl/fl mice and occur via activation of the NF-κB signaling cascade (18) (19) (20) , however, mechanisms by which the complex cytokine and chemokine network in the colonic microenvironment influences inflammatory MPh infiltration are not well defined and represent a fundamental gap in the understanding of homeostatic immune function and IBD development.
F-box and WD repeat domain-containing 7 (FBXW7) is a component of the SKP1, CUL1, and F-box protein type ubiquitin ligase (SCF) complex. Fbxw7 mutations have been identified in various types of cancers (21) . FBXW7 is also reported to regulate lipid metabolism (22) , target osteogenic and chondrogenic transcriptional factors (23) , interact with parkin, and play important roles in Parkinson's disease (24) . Our previous study showed that FBXW7 is critical for promoting innate antiviral immunity by mediating the ubiquitination of SHP2 (25) . However, the function and mechanisms of FBXW7 in inflammation responses have not been clarified. In this study, we found that FBXW7 expression was markedly increased in inflamed intestinal tissues from patients with UC or CD. Fbxw7 deficiency in myeloid cells reduced inflammation and disease severity in the colitis mouse model. FBXW7 promoted enhancer of zeste homolog 2 (EZH2) ubiquitination and decreased the modification of H3K27me3 on the promoters of the chemokines Ccl2 and Ccl7. We found that the FBXW7/EZH2/ CCL2/CCL7 pathway heightened the severity of colitis through recruitment of CX3CR1 int proinflammatory MPhs, and propose that FBXW7 may serve as a new diagnostic marker.
Results
Increased FBXW7 expression in IBD. We first analyzed the expression levels of FBXW7 in colonic mucosa samples, with or without signs of inflammation, from patients with UC in the Gene Expression Omnibus (GEO) database. Compared with healthy mucosa, FBXW7 expression was significantly increased in active UC mucosa, but less so in inactive UC mucosa (Supplemental Figure 1A; supplemental material available online with this article; https://doi.org/10.1172/JCI123374DS1). Moreover, the expression of FBXW7 in colon tissue macrophages observed by immunohistochemical and immunofluorescence staining ( Figure 1 , A and B) and mRNA expression of FBXW7 in peripheral blood monocytes ( Figure 1C ) were markedly increased in patients with IBD compared with healthy control subjects or non-IBD inflammation (acute diarrhea) control (ICs). FBXW7 mRNA levels in peripheral blood monocytes was significantly higher in patients with UC (Supplemental Figure 1B) or CD (Supplemental Figure 1C ), who had severe colitis, than in those with mild colitis or in healthy controls. However, we detected no difference in FBXW7 expression levels in peripheral blood lymphocytes from patients with IBD and control subjects ( Figure 1D ).
The expression of FBXW7 in CD11b + CX3CR1 + CLP macrophages ( Figure 2 , A and B) was significantly increased in the dextran sodium sulfate-induced (DSS-induced) colitis mouse model and in Il10 gene-KO (ll10 -/-) mice, and Fbxw7 mRNA expression in peripheral blood monocytes of mice ( Figure 2C ) showed a progressive increase upon DSS challenge. FBXW7 expression in Ly6C hi colonic monocytes was also dramatically increased ( Figure 2D Figure 5B ). Given that neutrophils express high levels of Lyz2 and can be recruited to inflamed tissue to exert antimicrobial effects, the expression of FBXW7 was also increased in peripheral blood and CLP neutrophils from mice with colitis compared with healthy mice. We then examined whether the attenuated colitis in LysM + Fbxw7 fl/fl mice was related to the neutrophils. We found that depletion of neutrophils by anti-Ly6G Ab could not abrogate the reduced inflammation phenotype of LysM + Fbxw7 fl/fl mice (Supplemental Figure 6 , C-G). These findings indicated that the function of Fbxw7 in colitis was not dependent on neutrophils.
To further confirm that the function of Fbxw7 in colitis was dependent on macrophages, we depleted macrophages using clodronate-containing liposomes (CLs) (26, 27) . Flow cytometric analysis confirmed a marked reduction in the percentages of local macrophages in mice treated with CLs (Supplemental Figure 7 , A and B). The protective effect of myeloid We next investigated the changes in myeloid cell subpopulations in CLP during colitis development by analyzing CD11b + CX3CR1 hi resident macrophages and CD11b + CX3CR1 int proinflammatory MPhs in the colon. We found that the accumulation of CX3CR1 int proinflammatory MPhs (red) increased with the severity of intestinal inflammation and finally reached its highest proportion on day 9 after DSS treatment in WT mice (Fbxw7 fl/fl ) ( Figure 4 , C and D). Importantly, KO mice (LysM + Fbxw7 fl/fl ) showed an obviously reduced accumulation of this CX3CR1 int cell population compared with Fbxw7 fl/fl littermates, starting the third day after DSS treatment, but we observed no difference in the frequency of CX3CR1 hi resident macrophages (blue) in LysM + Fbxw7 fl/fl and Fbxw7 fl/fl littermates during the colitis period ( Figure 4 , C and D). In addition, the percentage and number of Ly6C hi CX3CR1 int monocytes ( Figure 4E ) and the percentage of CD11b + Ly6G + neutrophils in CLP (Supplemental Figure 5A ) were lower in LysM + Fbxw7 fl/fl mice than in Fbxw7 fl/fl mice at the later, but not the early, stage of colitis, whereas the accumulation of CD103 + as the production of inflammatory cytokines during colonic inflammation (Supplemental Figure 7D ). We also confirmed the increased expression of Fbxw7 in sorted CX3CR1 hi resident macrophages and CX3CR1 int MPhs from C57BL/6 mice with Figure 9B ). Local inflammation and tissue damage in UC and CD are affected by local expression of specific chemokines within IBD tissues (29) , and DSS-induced colitis correlates directly with the CCR2-mediated accumulation of MPhs (30) . To address the mechanisms involved in the downregulation of intestinal inflammation by myeloid deficiency of Fbxw7, we sorted CX3CR1 hi resident macrophages, CX3CR1 int proinflammatory MPhs, and Ly6C hi monocyte populations. We found that CX3CR1 hi resident macrophages expressed markedly higher amounts of chemokines than did those in CX3CR1 int Figure 7E ). Taken together, these results suggested that myeloid Fbxw7 deficiency leads to a marked reduction in the accumulation of proinflammatory MPhs in the colitis microenvironment.
Fbxw7 deficiency downregulates Ccl2 and Ccl7 in resident macrophages. The abnormal phagocytosis of invading microbes by resident macrophages could induce excessive inflammation (28) . We first confirmed that Fbxw7 deficiency did not affect the phagocytic function of macrophages by detecting the phagocytotic efficiency of bone marrow-derived macrophages (BMDMs) from LysM + Fbxw7 fl/fl mice and Fbxw7 fl/fl littermates (Supplemental Figure 8A ) and did not influence the expression of phagocytosis-related genes (Mfge8, Timd4, Anxa1) in primary peritoneal and CLP macrophages (Supplemental Figure 8B ). We found that Fbxw7 deficiency in macro phages also did not affect the survival of macrophages after serum depletion (Supplemental Figure 8C ).
The inflammatory cytokines TNF-α and IL-6 are predominantly produced by inflammatory MPhs during colitis (3). We expressed genes and also revealed that myeloid Fbxw7 deficiency led to markedly decreased expression of various inflammationrelated genes, among which Ccl2 and Ccl7 are the most important ( Figure 5B ). The decrease in cytokine expression detected in colon tissue from LysM + Fbxw7 fl/fl mice at the later phase of colitis (9 days after DSS treatment) ( Figure 5A ) might be the consequence of the substantial decrease in inflammatory MPh infiltration. Compared with Fbxw7 fl/fl littermates, LysM + Fbxw7 fl/fl mice had markedly lower expression levels of Ccl2 and Ccl7 in the resident macrophage population, whose functions were mainly involved in the recruitment of monocytes ( Figure 5C ). Quantitative reverse transcription PCR (qRT-PCR) (Supplemental Figure 9 , D and E) and ELISA ( Figure  5D and Supplemental Figure 9F ) further confirmed that myeloid deficiency of Fbxw7 resulted in lower levels of CCL2 and CCL7 in macrophages from mice with colitis. Moreover, macrophagedepleted LysM + Fbxw7 fl/fl mice and Fbxw7 fl/fl littermates showed similar expression levels of the chemokines CCL2 and CCL7 (Figure 5D ). We also observed a significant correlation between Fbxw7 mRNA and Ccl2 mRNA levels in colonic mucosal samples from patients with UC in the GEO database (Supplemental Figure 9G ). Collectively, these results suggested that myeloid Fbxw7 deficiency decreases the production of Ccl2 and Ccl7 in resident macrophages. Monocyte migration from peripheral blood during infection or inflammation requires CCL2/CCL7/CCR2 signaling (31); therefore, we performed a Transwell migration assay to compare the chemoattractive function of resident macrophages from LysM + Fbxw7 fl/fl mice and Fbxw7 fl/fl littermates in vitro (Supplemental Figure 10, A and B) and found that LysM + Fbxw7 fl/fl resident macrophages recruited fewer monocytes than did macrophages from Fbxw7 fl/fl littermates in a Transwell assay ( Figure 5E and Supplemental Figure 10C ). Furthermore, CCL2 and CCL7 production was decreased in the culture supernatant of CX3CR1 hi resident macrophages from LysM + Fbxw7 fl/fl mice compared with macrophages from Fbxw7 fl/fl littermates ( Figure 5F ). Compared with resident macrophages, the culture supernatant of proinflammatory MPhs from both LysM + Fbxw7 fl/fl and Fbxw7 fl/fl littermate mice showed a weaker ability of the macrophages to recruit monocytes ( Figure 5E and Supplemental Figure 10C ) with lower levels of chemokines ( Figure 5F ). Importantly, neutralization of CCL2 and CCL7 abrogated the difference in the monocyte-recruiting ability of Fbxw7 fl/fl and LysM + Fbxw7 fl/fl resident macrophages ( Figure  5G and Supplemental Figure 10D ). This observation suggested that decreased production of CCL2 and CCL7 in LysM + Fbxw7 fl/fl resident macrophages contributed to the reduced recruitment of Ly6C hi monocytes. Furthermore, anti-CCL2 and anti-CCL7 Abs decreased the number of inflammatory MPhs that infiltrated into the colons of both Figure 5J ). Collectively, these data further support the idea that Fbxw7 deficiency decreases the expression of CCL2 and CCL7 in resident macrophages and thereby reduces the accumulation of proinflammatory MPhs during colitis progression.
FBXW7 interacts with EZH2. To identify the mechanisms regulating CCL2 and CCL7 production in colon-resident macrophages, we assessed the activation of NF-κB and HIF-1α (32, 33) signaling pathways in BMDMS during the LPS-induced response. We found no potent difference in these signaling pathways between Fbxw7 fl/fl and LysM + Fbxw7 fl/fl BMDMs after LPS stimulation ( Figure 6, A and B) . These results raise the possibility of epigenetic regulation of the Ccl2 and Ccl7 genes in response to inflammatory stimuli. We next assessed changes in histone modifications and found that the modification of H3K27me3 was markedly increased in LysM + Fbxw7 fl/fl BMDMs compared with Fbxw7 fl/fl BMDMs after LPS stimulation ( Figure 6C ). EZH2 was found to be an important enzyme for H3K27me3 (34) , and we observed a decrease in the expression of EZH2 protein in BMDMs after LPS challenge (Supplemental Figure 12A ). The expression of EZH2 was also decreased in CD11b + macrophages from CLP of mice with IBD compared with macrophages from healthy controls (Supplemental Figure 12B ). We speculated that EZH2 protein expression negatively correlates with FBXW7 levels in CLP macrophages. We found higher EZH2 protein expression levels in Fbxw7-deficient BMDMs than in Fbxw7 fl/fl BMDMs upon LPS stimulation ( Figure 6D ). Furthermore, the interaction of endogenous EZH2 and FBXW7 in BMDMs was increased after LPS challenge ( Figure 6E ). We consistently found that FBXW7 colocalized with EZH2 upon LPS stimulation in BMDMs ( Figure 6F) .
FBXW7 recognizes and binds to substrates through a stretch of eight WD40 repeat domains (34) , and the binding consensus motif (T/S)PXX(S/T/D/E) has been identified in several FBXW7 substrates, including c-Myc, cyclin E1, and c-Jun (36) (37) (38) . Protein motif analysis showed that 2 domains in the EZH2 protein sequence might be the FBXW7 binding motif ( Figure 6G ). To determine whether those amino acid sequences were required for FBXW7 recognition and ubiquitination, we constructed 3 mutants of EZH2, in which serine residues at positions 261, 265, and/or 367, and 371 were replaced with glycine residues. The results showed that mutant EZH2 (261, 265A) and mutant EZH2 (367, 371A) bound to FBXW7 less efficiently than did EZH2, and that mutant EZH2 (261, 265, 367, and 371) could not bind to FBXW7 ( Figure 6H ). These results strongly suggest that the serine at positions 261, 265, 367, and 371 of EZH2 was critical for its interaction with FBXW7.
FBXW7 mediates the degradation and ubiquitination of EZH2. We confirmed that EZH2 was the target of FBXW7 in macrophages, as there was no significant difference between Fbxw7 fl/fl and LysM + Fbxw7 fl/fl BMDMs in terms of Ezh2 mRNA expression levels upon LPS stimulation (Supplemental Figure 12C ). However, we found that the decrease in EZH2 protein expression after LPS stimulation (Supplemental Figure 12A ) was completely blocked by the proteasome inhibitor MG132 ( Figure 7A) . A cycloheximide chase assay showed that FBXW7 deficiency extended the half-life of endogenous EZH2 protein in BMDMs (Figure 7 , B and C). These data indicated that FBXW7 might induce EZH2 degradation through proteasomes. Exogenously expressed EZH2 was degraded by overexpressed FBXW7 in HEK293 cells, which was also abrogated by MG132 ( Figure 7D ). jci.org Volume 129
Number 9 September 2019 ubiquitination of EZH2 was mediated by FBXW7 in a dosedependent manner ( Figure 7F ). FBXW7 could induce K48linked polyubiquitination of EZH2 ( Figure 7G ). Furthermore, FBXW7 deficiency in macrophages almost canceled K48-linked polyubiquitination of endogenous EZH2 compared with WT However, FBXW7 could not decrease the expression of mutant EZH2 (position 4A) ( Figure 7E ). Collectively, these results indicated that EZH2 could be degraded by FBXW7 via the ubiquitinproteasome system. Our study to determine whether FBXW7 functions as an E3 ubiquitin ligase of EZH2 revealed that the mal promoter of the Ccl2 gene in a clock gene BMAL1-dependent manner (39) . We hypothesized that FBXW7 increases the expression of CCL2 and CCL7 chemokines by decreasing the protein levels of EZH2. Ezh2 was knocked down by Ezh2 siRNA (siEzh2) in BMDMs, siEzh2 reduced expression of EZH2 and H3K27me3 macrophages ( Figure 7H ). Together, these data demonstrate that FBXW7 promotes K48-linked polyubiquitination and proteasome degradation of EZH2 in macrophages. EZH2 inhibits macrophage Ccl2 and Ccl7 expression by H3K27me3 modification. EZH2 has been shown to be recruited to the proxi- the GFP-pAAV-shFbxw7 vector was verified in C57BL/6 mice by immunofluorescence (Supplemental Figure 13A ) and qRT-PCR (Supplemental Figure 13B ). AAV-shFbxw7 treatment decreased mucosal ulcerations in Il10 -/colitis mice (Figure 9, A and B) . In the DSS-induced colitis model, AAV-shFbxw7-treated C57BL/6 mice had less of body weight loss, a lower DAI ( Figure 9C) , and an alleviated colon phenotype and shortening (Figure 9 , D and E) when compared with AAV-shNC mice. Moreover, AAV-shF-bxw7-treated mice showed significantly decreased expression of Ccl2 and Ccl7 in colon tissues, but significant change in expression of Ccr2 and Cx3cl1 ( Figure 9F ). Furthermore, AAV-shFbxw7 treatment significantly improved the survival of mice with colitis ( Figure 9G ) compared with AAV-shNC-treated mice. Altogether, these results suggest that AAV-mediated colonic Fbxw7 silencing protects mice with colitis against inflammation and disease progression by downregulating Ccl2 and Ccl7 expression.
Discussion
The E3 ubiquitin ligase FBXW7 is mutated in approximately 10% of human colon cancers; it acts as a tumor suppressor in several tissues and targets multiple transcriptional activators and protooncogenes for ubiquitin-mediated degradation (41) . However, the role of FBXW7 in inflammation and the immune response remains unknown. In this study, we revealed a mechanism for the mediation of IBD progression, whereby FBXW7 promotes Ccl2 and Ccl7 levels as compared with the control siRNA (siNC) ( Figure 8A ). Knockdown of Ezh2 enhanced Ccl2 and Ccl7 mRNA expression in BMDMs and mitigated the difference in LPS-induced CCL2 and CCL7 expression between Fbxw7 fl/fl and LysM + Fbxw7 fl/fl BMDMs ( Figure 8B) . To test the direct effect of EZH2-associated H3K27me3 on expression of CCL2 and CCL7, we treated BMDMs with GSK126, an EZH2-specific competitive inhibitor compound (40) , which induced loss of EZH2-associated H3K27me3, without any change in EZH2 protein abundance ( Figure 8C ).Treatment with GSK126 also showed consistently similar results with siEzh2 ( Figure 8D ). These data indicate that FBXW7 regulates CCL2 and CCL7 expression via EZH2-associated H3K27me3. A ChIP assay revealed greater H3K27me3 modification in the proximal promoter areas of Ccl2 and Ccl7 in LysM + Fbxw7 fl/fl BMDMs than in those in Fbxw7 fl/fl BMDMs ( Figure 8E ). These data suggest that FBXW7 promotes CCL2 and CCL7 chemokine expression by inhibiting EZH2-dependent methylation of H3K27 at the Ccl2 and Ccl7 gene promoters. Reducing Fbxw7 expression alleviates colitis. The results described above demonstrated that FBXW7 expression was positively correlated with the severity of colitis, underscoring the therapeutic potential of FBXW7. To further explore the therapeutic importance of FBXW7 in colitis, recombinant adeno-associated virus (AAV-shFbxw7 or AAV-shNC vector as a control) was injected into the proximal bowel in mice. High-efficiency transduction of Furthermore, it is highly probable that the disappearance of the difference in colitis severity between Fbxw7 fl/fl and LysM + Fbxw7 fl/fl mice was due to the elimination of macrophages. Altered profiles of inflammatory molecules and inflammationrelated signaling pathways involving cytokines, chemokines, inflammasomes, antimicrobial peptides, and neuropeptides are all involved in the pathogenesis of CD and UC (3). The degree of local inflammation and tissue damage in UC and CD is dependent on the local expression of specific chemokines within IBD tissues. GWAS have pointed to several IBD susceptibility loci that contain genes that encode proteins involved in chemokine signaling, including CC-chemokine receptor 6 (CCR6), CCL2, and CCL13. A recent study has reported that treatment of intestinal crypts with super natants of commensal-specific T cells from patients with CD induced higher protein secretion of the chemokines CXCL8 and CXCL1 and prompted a predominant neutrophil and Th17 recruitment to the intestinal epithelium (43) . The expression of Il17C mRNA has been shown to correlate with CCL20 in the inflamed expression through the degradation of EZH2 in CX3CR1 hi resident macrophages, which results in increased recruitment of CX3CR1 int MPhs and amplification of intestinal inflammation. We believe our work provides new insights into the molecular and cellular networks of the intestinal inflammatory microenvironment.
A constant balance between resident macrophages and inflammatory MPhs is critical for maintaining homeostasis in a healthy gut and ensuring protective immunity when required. Interestingly, we noticed a more marked reduction of CD11b + CX-3CR1 hi resident macrophages compared with CD11b + CX3CR1 int inflammatory MPhs after liposome injection. This preferential ability may be due to the greater phagocytic activity of CD11b + CX-3CR1 hi resident macrophages (42) , which are key players in the capture and destruction of invading pathogens, as well as in the clearance of apoptotic or senescent cells. Our findings suggested that the increased susceptibility to DSS-induced colitis of both Fbxw7 fl/fl and LysM + Fbxw7 fl/fl mice after liposome treatment was related to the depletion of resident macrophages in the colon. Han (National Key Laboratory of Medical Immunology and Institute of Immunology, Second Military Medical University, Shanghai, China). All mice were bred at the Zhejiang University Laboratory Animal Center under specific pathogen-free conditions. C57BL/6 mice were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). Mice were born and bred at the same facility and kept on the same rack in an animal housing room that was maintained under specific pathogen-free conditions with a controlled temperature (22°C) and photoperiod (12-hour light/12-hour dark cycle) and unrestricted access to standard mouse chow and water, except for mice used in some experiments described herein. The cohousing experiments were conducted with weaned 3-week-old Fbxw7 fl/fl mice that were randomly cohoused with age-matched LysM + Fbxw7 fl/fl mice at a 1:1 ratio for 7 weeks prior to DSS colitis induction, which was performed during the cohousing period.
Abs against the HA tag (sc-805), Myc tag (sc-40; sc-789), Flag tag (sc-807), GAPDH (sc-130619), and ubiquitin (sc-271289) were obtained from Santa Cruz Biotechnology. Abs specific for p-p65 (product no. 3033), p65 (product no. 8242), EZH2 (product no. 3147), and HIF-1α (product no. 36169) were from Cell Signaling Technology. Lys48-specific linked polyubiquitin Ab (product no. 05-1307) was from MilliporeSigma. Abs against FBXW7 were obtained from Abcam (ab12292) and Thermo Fisher Scientific . Abs against H3K36me3 (ab9050), H3K9me3 (ab8898), H3K4me3 (ab8580), H3K27me3 (ab6002), and H3 (ab1791) were from purchased from Abcam. MG132 (M8699), CHX (C4859), and Flag-M2 Magnetic Beads (product no. M8823) were from MilliporeSigma. ELISA kits for mouse IL-6 (BMS603-2), TNF-α (BMS607-3), CCL2 (BMS6005), and CCL7 (BMS6006INST) were purchased from eBioscience.
Human peripheral blood samples. A total of 68 peripheral blood samples were collected from patients with IBD hospitalized in Sir Run Run Shaw Hospital (Zhejiang University School of Medicine, China) from May 11, 2017 to August 1, 2017, and from 50 healthy adults as a control group. The diagnosis and IBD severity evaluation were made according to the 2012 Expert Consensus Document on the Diagnosis and Treatment of IBD formulated by the Chinese Society for Gastroenterology (CSGE) (54) . The severity of CD was determined using the Best CD activity index (CDAI) calculator (55) . The severity of UC disease was determined by the Mayo Score with composite indices (56) . Basic information concerning the patients, including age and sex, is summarized in Supplemental Table 1 . Monocytes were isolated using a human monocyte isolation kit (Haoyang Biological Technology Co.) according to the manufacturer's recommendations.
Randomization method. The following covariates for mice were controlled: age, sex, littermate status, and age (8-10 weeks). Adult male mice and their littermates were used. Under such conditions, the mice were randomly assigned to experimental groups. For studies using media collected from stimulated cells or tissues, samples were randomly allocated to ELISA plate wells prior to measurement. Random fields were analyzed in confocal H&E-stained and immunohistochemical images.
Fecal microbiome analysis. LysM + Fbxw7 fl/fl mice and Fbxw7 fl/fl littermates (8-to 10-week-old male or female C57BL/6J mice) were fed in different cages. The mice were kept in the same environment with the other experimental mice. Freshly formed feces were collected from the cage and weighed. Bacterial DNA was extracted from the stool colon of patients with IBD (44) . We found that upregulated Fbxw7 in macrophages of the inflamed intestine promotes CCL2 and CCL7 production to facilitate the progression of colitis via the potent recruitment of proinflammatory MPhs. On the other hand, a protective role of Fbxw7 in intestinal epithelium during acute intestinal inflammation has also been reported, as deletion of Fbxw7 in the intestinal epithelium was found to promote DSS-induced colitis through activation of NF-κB signaling (45) . This finding and our study revealed the differential function of Fbxw7 in intestinal epithelium and myeloid cells within the intestinal microenvironment.
Recent studies have shown that, during inflammation, epigenetic mechanisms determine the unique tissue-specific identity and function of macrophages (46, 47) . Trimethylation of H3K4 on cytokine gene promoters was shown to be induced in active M1 macrophages in response to TLR stimulation, leading to chromatin remodeling and inflammatory gene expression (48) . IFNdependent histone acetylation regulation instructs the development of the colitogenic monocyte and macrophage lineage in vivo during inflammation, suggesting a new insight into how macrophages gain colitogenic properties during the development of colitis (49) . Demethylase KDM6A has been reported to promote transcription of the cytokines IL-6 and IFN-β in primary macrophages during the innate immune response through demethylation of H3K27me3 at the II6 and Ifnb promoters (50) . A selective H3K27 demethylase inhibitor was also demonstrated to reduce LPSinduced proinflammatory cytokine production by human primary macrophages (51) . EZH2, acting as a catalytic subunit of PRC2, is critical in mediating the formation of H3K27me3, which is associated with transcriptional gene suppression (34) . Ezh2 deficiency has been shown to affect TNF-α signaling and promote the inflammatory response in intestinal epithelial cells in colitis (52) . We provide evidence that threonine at positions 261 and 367 of EZH2 is essential for the interaction of EZH2 with FBXW7 and that this interaction mediates the function of FBXW7 in reducing EZH2 expression in resident macrophages upon DSS challenge. The relationship between FBXW7 and epigenetic modifiers has been reported in tumorigenesis (53) , but it remains largely unknown in inflammation. Here, we have demonstrated that expression of CCL2 and CCL7 produced by resident macrophages from LysM + Fbxw7 fl/fl mice was lower than that in macrophages from Fbxw7 fl/fl littermates and that a selective inhibitor of H3K27me3 in macrophages had the effect of promoting Ccl2 and Ccl7 expression.
In summary, we identified a critical role of FBXW7 in the regulation of colitis by inducing Ccl2 and Ccl7 expression in resident macrophages and promoting the accumulation of proinflammatory MPhs. FBXW7/EZH2/CCL2/CCL7 is an important pathway for shaping the status and activity of colon-resident macrophages and inflammatory MPhs in the colitis setting. Our results indicate that FBXW7 may be a predictive marker of IBD severity and a potential target for IBD treatment, since Fbxw7 siRNA had a significant therapeutic effect in our colitis mouse model.
Methods
Mice and reagents. Fbxw7 fl/fl mice (on a C57BL/6J background) were obtained from The Jackson Laboratory. LysM-Cre mice on a C57BL/6J background were provided by Ximei Wu (Zhejiang University School of Medicine, Hangzhou, China). Il10 -/mice were provided by Yanmei jci.org Volume 129 Number 9 September 2019
40-1500). The cells were analyzed with a NovoCyte Flow Cytometer (ACEA) or a BD Fortessa, or were sorted with a BD FACSAria machine. Flow cytometric analysis was performed using FlowJo software. Gene expression analysis. Total RNA was extracted from cells using TRIzol Reagent (Takara) according to the manufacturer's directions. Subsequently, single-strand cDNA synthesis was performed using a Tyobo reverse transcription kit. For the DSS-induced colitis model, RNA reverse transcription was performed as previously described (61) . Total cDNA from macrophages and monocytes sorted from mouse colons was extracted using a Single Cell Sequence Specific Amplification Kit (Vazyme). qRT-PCR was performed using SYBR Green Master Rox (Roche) on a CFX-96 (Bio-Rad) or 480II (Roche) Real-Time PCR System, and Actb was used as a housekeeping gene. The primer sequences are listed in Supplemental Table 2 .
Monocyte transfer experiment. Briefly, mice received a sublethal dose of γ ray irradiation (8 Gy) to induce BM cell damage on day 3 or 7 after DSS challenge. Six hours after irradiation, LysM + Fbxw7 fl/fl (KO) mice and Fbxw7 fl/fl littermate (WT) mice received 100 μL fresh WT and KO mixed monocytes labeled with cell proliferation Dye eFluor 450 (eBioscience, 65-0842-90) and eFluor 670 (eBioscience, 65-0840-85) at a concentration of 1 × 10 7 /mL, respectively (WT plus KO→WT and WT plus KO→KO groups). Ly6C hi monocytes were sorted to high purity (>95%), and 1 day after monocyte transfer, CLP from mice was collected and analyzed by flow cytometry.
Migration assay. Sorted splenic Ly6C hi monocytes (1 × 10 4 ) from Fbxw7 fl/fl and LysM + Fbxw7 fl/fl mice were added into the upper compartment of the Transwell chambers (24-well plates, 8-mm pores, BD Biosciences) in 100 μL serum-free medium. Sorted CX3CR1 hi resident or CX3CR1 int proinflammatory MPhs (5 × 10 5 ) from CLP of Fbxw7 fl/fl mice or LysM + Fbxw7 fl/fl mice with colitis were cultured in 600 μL RPMI 1640 serum-free medium. After 24 hours, the culture supernatant was harvested and added into the lower chamber of the Transwell plate as a chemotactic stimulus. In some conditions, CCL2 (R&D Systems, AF-479-NA) and CCL7 (R&D Systems, AF-456-NA) Abs were added to the conditioned medium in the lower chamber 2 hours before incubation. After a 24-hour inoculation at 5% CO 2 and 37°C, the cells that had dropped into the lower chamber were counted by cytometry, and cells that clung to the bottom side of the polycarbonate membrane were fixed with 10% formalin and stained with DAPI.
For the in vivo migration assay, every 48 hours on days -1, 1, 3, and 5 during DSS treatment, mice were i.p. injected with anti-CCL2 and anti-CCL7 Abs (R&D Systems, AF-479-NA and AF-456-NA) or a rat IgG2a isotype control mAb (BioLegend, RTK2758) diluted in sterile PBS.
Phagocytosis assay. Fluorescein conjugate E. coli (K-12 strain) BioParticles (Molecular Probes, E2861, FITC-labeled heat-killed E. coli) were diluted in serum media and incubated for 30 minutes, followed by 2 washes in PBS. Next, FITC-labeled, heat-killed E. coli was added to RPMI-1640 medium with 10% FCS and incubated with cells for 1 hour in a humidified atmosphere of 5% CO 2 at 4°C or 37°C, and cells were washed twice with PBS before trypsinization and then washed once with trypan blue, followed by flow cytometric analysis.
Depletion of macrophages. Macrophages were depleted using CLs (ClodronateLiposomes.org) as described previously (62) . In brief, mice were anesthetized, and CLs were injected via the tail vein (100 μL) and i.p. (100 μL) into mice on days -1, 1, 3, and 5 during DSS treatment. Liposome-encapsulated PBS was not used as a negative control, because the uptake of these liposomes by colonic macrophages was using a QIAamp Fast DNA Stool Mini Kit (QIAGEN). DNA concentration and purity were monitored on 1% agarose gels, after which DNA was diluted to 1 ng/μL using sterile water.
Amplicon generation, PCR products mixing and purification, library preparation, and sequencing of the 16S rDNA gene were performed by Novogene Bioinformatics Technology to determine bacterial composition and diversity, using IonS5 XL 16S rDNA amplicon sequencing. Sequencing libraries were generated using a 48-Reaction Ion Plus Fragment Library Kit (Thermo Fisher Scientific) following the manufacturer's recommendations. Data analysis was also conducted by Novogene Bioinformatics Technology according to the previous literature (57, 58) . Statistical analysis of sequencing data was performed using UPARSE software, version 7.0.100 (http://drive5.com/uparse/) (59) . Sequences with 97% or greater similarity were assigned to the same OTUs.
Cell culture. HEK293T cells (American Type Culture Collection [ATCC], CRL-11268) were maintained in DMEM medium, and thioglycolate-elicited mouse peritoneal macrophages (BD, 3190383; Merck, 1.08191.0500) were cultured in RPMI 1640 medium with 10% (vol/vol) FCS. BMDMs were generated using BM from femurs and tibiae of 6-to 8-week-old mice (25) .
Induction of colitis. Eight-to ten-week-old LysM + Fbxw7 fl/fl C57BL/6 mice and Fbxw7 fl/fl littermates were studied using TNBS or DSS-induced colitis models as described previously (60) . Mice were treated with 3% DSS (MP Biomedical) in the drinking water (w/v) for 7 days, followed by 2 days of regular drinking water before sacrifice. In the recovery experiment, LysM + Fbxw7 fl/fl mice and Fbxw7 fl/fl littermates were treated with DSS for 7 days, followed by a 13-day recovery period, and control mice were treated with water. In the survival experiment, the mice were given 4% DSS in the drinking water for 7 days, followed by regular drinking water until the end of the study.
Overnight-fasted mice were intrarectally injected with 100 mg/kg TNBS (MilliporeSigma) in 50% ethanol, with 50% ethanol treatment used as a control. The LysM + Fbxw7 fl/fl mice and Fbxw7 fl/fl littermates were sacrificed 5 days after TNBS treatment.
Il10 -/mice spontaneously developed chronic IBD under specific pathogen-free conditions in our animal facility. The phenotypes of chronic enterocolitis were more evident when Il10 -/mice were 12 weeks of age or older.
Analysis of colon explant cultures and ELISA. The colons of mice were flushed with PBS containing 30% antibiotics, and open along a longitudinal axis. Then, pieces of tissue (~ 3-mm 2 ) were obtained from the distal colon and incubated for 24 hours in RPMI supplemented with 10% FCS and 20% antibiotics (1 punch biopsy/100 mL medium). Supernatants were collected and kept frozen until assessment. CCL2 and CCL7 levels in the supernatant were detected by conventional double-sandwich ELISA (BD Biosciences).
Flow cytometry. The following fluorochrome-labeled mAbs and staining reagents were used according to the manufacturers' protocols: lamina propria cells were stained with anti-CD11b-FITC (BioLegend, 101217), anti-Ly6C-FITC (BioLegend, 128005), anti-Gr-1-FITC (BioLegend, 108417), anti-CD11b-PE (BioLegend, 101208), anti-CX3CR1-PE (Bio-Legend, 149006), anti-CD11C-APC (BioLegend, 117310), anti-F4/80-FITC (BioLegend, 123120), anti-Ly6G-FITC (BioLegend, 127605), anti-CD45.2-APC (eBioscience, 104), anti-Ly6C-percp cy5.5 and a Zombie Violet Fixable Viability Kit (BioLegend, 423114), anti-F4/80-CF594 (BioLegend, 123131), anti-CD103-BV605 (BD, 740355), anti-EZH2-FITC (BD, 562479), and anti-human Cdc4 (Thermo Fisher Scientific,
